| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| EBITDA | 345 | 74.7 | +362.3% |
| Profit before tax | 352 | 77.7 | +352.7% |
| Net profit | 265 | 54.9 | +382.3% |
| EPS | ₹4.50 | ₹0.92 | +389.1% |
| Tap a line for its trend | Q2 FY27Sep 2026 | Q1 FY27Jun 2026 | Q4 FY26Mar 2026 | Q3 FY26Dec 2025 | Q2 FY26Sep 2025 | Q1 FY26Jun 2025 | Q4 FY25Mar 2025 |
|---|
| 6.2 | 7.5 | 1.9 | 1.7 | 3.0 | 0.4 | 2.4 | |
Expenses | |||||||
| 290 | 283 | — | — | — | — | — | |
| 345 | 734 | 149 | 172 | 74.7 | 352 | −3.3 | |
| 345 | 734 | 149 | 172 | 74.7 | 352 | −3.3 | |
Profit | |||||||
| 352 | 742 | 151 | 173 | 77.7 | 352 | −0.9 | |
| 250 | 130 | — | — | — | — | — | |
| −164 | 61.8 | — | — | — | — | — | |
| 265 | 550 | 111 | 128 | 54.9 | 263 | 0.5 | |
| 266 | 550 | — | — | — | — | — | |
Per share | |||||||
| ₹4.50 | ₹9.34 | ₹1.89 | ₹2.18 | ₹0.92 | ₹4.47 | ₹0.01 | |
| ₹4.49 | ₹9.33 | — | — | — | — | — | |
Revenue detail — as filed | |||||||
| — | — | 4,545 | 4,445 | 4,266 | 4,115 | 3,987 | |
| 268 | 644 | — | — | — | — | — | |
| — | — | 216 | 192 | 182 | 177 | 186 | |
Expense detail — as filed | |||||||
| — | — | 629 | 519 | 441 | 395 | 458 | |
| 770 | 660 | — | — | — | — | — | |
| — | — | 793 | 682 | 691 | 508 | 760 | |
| — | — | 793 | 682 | 691 | 508 | 760 | |
| — | — | 19.0 | 19.3 | 18.3 | 15.2 | 15.1 | |
| — | — | 0.2 | 0.1 | 0.0 | 0.0 | 0.4 | |
Profit build-up — alternate / pre-Ind-AS tags | |||||||
| — | — | 151 | 173 | 77.7 | 352 | −0.9 | |
| 352 | 742 | — | — | — | — | — | |
| — | — | 151 | 173 | 77.7 | 352 | −0.9 | |
| — | — | 39.9 | 45.2 | 22.8 | 89.5 | −1.4 | |
| — | — | 111 | 128 | 54.9 | 263 | 0.5 | |
| — | — | 111 | 128 | 54.9 | 263 | 0.5 | |
Other comprehensive income — detail | |||||||
| 1.1 | 0.0 | — | — | — | — | — | |
| 1.5 | — | — | — | — | — | — | |
| 0.4 | 0.0 | — | — | — | — | — | |
Per share — as-filed variants | |||||||
| ₹4.50 | ₹9.34 | — | — | — | — | — | |
| ₹4.49 | ₹9.33 | — | — | — | — | — | |
| — | — | ₹1.89 | ₹2.18 | ₹0.93 | ₹4.47 | ₹0.01 | |
| — | — | ₹1.89 | ₹2.18 | ₹0.92 | ₹4.47 | ₹0.01 | |
Appropriations & transfers | |||||||
| — | — | 64.0 | 69.2 | −19.2 | 249 | −86.9 | |
| — | — | 7,001 | 6,890 | 6,755 | 6,699 | 6,436 | |
Insurance — revenue account (Policyholders') | |||||||
| — | — | 4,327 | 4,250 | 4,081 | 3,938 | 3,798 | |
| — | — | 5,968 | 4,624 | 4,424 | 3,605 | 5,138 | |
| — | — | 5,599 | 4,361 | 4,233 | 3,457 | 4,820 | |
| — | — | 884 | 780 | 676 | 620 | 684 | |
| — | — | 18.8 | 19.2 | 18.3 | 15.2 | 14.6 | |
| — | — | 2,641 | 3,055 | 2,828 | 2,763 | 2,655 | |
| 3,498 | 3,319 | 2,805 | 2,913 | 2,918 | 2,739 | 2,630 | |
| — | — | 164 | −142 | 90.0 | −24.3 | −24.5 | |
Insurance — Shareholders' account | |||||||
| — | — | 170 | 193 | 96.0 | 367 | 14.2 | |
| — | — | 105 | 123 | 115 | 118 | 97.0 | |
| — | — | 64.0 | 69.2 | −19.2 | 249 | −86.9 | |
| — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Insurance — result & transfers | |||||||
| — | — | −154 | −125 | −204 | 71.7 | −275 | |
| — | — | 64.0 | 69.2 | −19.2 | 249 | −86.9 | |
| — | — | 1.7 | 0.1 | 0.2 | 0.5 | 4.1 | |
Insurance — IRDAI ratios (as filed, not percentages) | |||||||
| 2.05× | 2.09× | 2.05× | 2.14× | 2.15× | 2.22× | 2.21× | |
| ₹2.05 | ₹2.09 | ₹2.05 | ₹2.14 | ₹0.02 | ₹2.22 | ₹2.21 | |
| — | — | ₹0.95 | ₹1.02 | ₹1.04 | ₹1.02 | ₹0.99 | |
| — | — | ₹0.65 | ₹0.69 | ₹0.72 | ₹0.70 | ₹0.69 | |
| — | — | ₹0.94 | ₹0.94 | ₹0.96 | ₹0.96 | ₹0.94 | |
| — | — | ₹0.30 | ₹0.34 | ₹0.33 | ₹0.33 | ₹0.30 | |
Regulatory disclosures — filed alongside, not part of the P&L | |||||||
| — | — | ₹0.00 | ₹0.00 | ₹0.00 | −₹1.00 | −₹1.00 | |
| — | — | ₹0.00 | ₹0.00 | ₹0.00 | ₹1.00 | ₹1.00 | |
| 14.6 | — | 6.8 | — | 5.2 | — | 7.5 | |
Adjusted (ex-exceptional items) — derived | |||||||
| 265 | 550 | — | — | — | — | — | |
| ₹4.50 | ₹9.34 | — | — | — | — | — | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 3 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | Q2 FY27 30/09/2026 | |
|---|---|---|---|---|---|---|---|---|
| Other Income | 2.4 | 0.4 | 3.0 | 1.7 | 1.9 | 7.5 | 6.2 | |
| Expenses | ||||||||
| + Other Expenses | — | — | — | — | — | 283.0 | 290.0 | |
| EBITDA | -3.3 | 351.7 | 74.7 | 171.7 | 149.3 | 734.2 | 345.5 | |
| EBIT | -3.3 | 351.7 | 74.7 | 171.7 | 149.3 | 734.2 | 345.5 | |
| Profit | ||||||||
| Pretax Income | -0.9 | 352.0 | 77.7 | 173.4 | 151.2 | 741.7 | 351.6 | |
| + Current Tax | — | — | — | — | — | 130.2 | 250.5 | |
| + Deferred Tax | — | — | — | — | — | 61.8 | -163.6 | |
| Net Income | 0.5 | 262.5 | 54.9 | 128.2 | 111.3 | 549.7 | 264.8 | |
| Total Comprehensive Income | — | — | — | — | — | 549.7 | 265.9 | |
| Per Share | ||||||||
| Basic EPS | 0.01 | 4.47 | 0.92 | 2.18 | 1.89 | 9.34 | 4.50 | |
| Diluted EPS | — | — | — | — | — | 9.33 | 4.49 | |
| Revenue Detail — as filed | ||||||||
| + Operating Income | 3,986.6 | 4,115.2 | 4,265.7 | 4,444.6 | 4,545.4 | — | — | |
| + Investment Income | — | — | — | — | — | 643.7 | 267.6 | |
| + Income from Investments (net) | 185.9 | 176.6 | 181.9 | 192.5 | 216.4 | — | — | |
| Expense Detail — as filed | ||||||||
| + Employee Remuneration & Welfare | 458.1 | 394.7 | 441.0 | 518.8 | 628.8 | — | — | |
| + Commission | — | — | — | — | — | 660.3 | 770.4 | |
| + Commission (net) | 759.8 | 507.8 | 690.9 | 682.1 | 792.6 | — | — | |
| + Commission & Brokerage (net) | 759.8 | 507.8 | 690.9 | 682.1 | 792.6 | — | — | |
| + Non-operating Expense | 15.1 | 15.2 | 18.3 | 19.3 | 19.0 | — | — | |
| + Non-operating Provision — Doubtful Debts | 0.4 | 0.0 | 0.0 | 0.1 | 0.2 | — | — | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | ||||||||
| Profit before Extraordinary Items | -0.9 | 352.0 | 77.7 | 173.4 | 151.2 | — | — | |
| Profit / (Loss) before Tax | — | — | — | — | — | 741.7 | 351.6 | |
| Profit / (Loss) before Tax — alt tag | -0.9 | 352.0 | 77.7 | 173.4 | 151.2 | — | — | |
| + Provision for Tax | -1.4 | 89.5 | 22.8 | 45.2 | 39.9 | — | — | |
| Profit / (Loss) after Tax | 0.5 | 262.5 | 54.9 | 128.2 | 111.3 | — | — | |
| Profit Carried to Balance Sheet | 0.5 | 262.5 | 54.9 | 128.2 | 111.3 | — | — | |
| Other Comprehensive Income — detail | ||||||||
| + Other Comprehensive Income | — | — | — | — | — | 0.0 | 1.1 | |
| + Items NOT to be Reclassified to P&L | — | — | — | — | — | — | 1.5 | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | 0.0 | 0.4 | |
| Per Share — as-filed variants | ||||||||
| Basic EPS — Continuing Operations | — | — | — | — | — | 9.34 | 4.50 | |
| Diluted EPS — Continuing Operations | — | — | — | — | — | 9.33 | 4.49 | |
| Basic & Diluted EPS before Extraordinary (not annualised) | 0.01 | 4.47 | 0.93 | 2.18 | 1.89 | — | — | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 0.01 | 4.47 | 0.92 | 2.18 | 1.89 | — | — | |
| Appropriations & Transfers | ||||||||
| + Transfer to Profit & Loss Account | -86.9 | 248.6 | -19.2 | 69.2 | 64.0 | — | — | |
| Reserves & Surplus excl. Revaluation Reserve | 6,435.9 | 6,698.6 | 6,755.4 | 6,889.6 | 7,000.8 | — | — | |
| Insurance — Revenue Account (Policyholders') | ||||||||
| Premium Earned | 3,798.3 | 3,938.3 | 4,080.8 | 4,250.4 | 4,327.2 | — | — | |
| + Gross Premiums Written | 5,138.0 | 3,605.5 | 4,423.8 | 4,624.2 | 5,968.4 | — | — | |
| + Net Premium Written | 4,819.6 | 3,457.4 | 4,233.4 | 4,360.9 | 5,598.6 | — | — | |
| + Operating Expenses — Insurance Business | 683.6 | 619.7 | 676.4 | 779.9 | 883.9 | — | — | |
| + Non-operating Expenses — Non-insurance | 14.6 | 15.2 | 18.3 | 19.2 | 18.8 | — | — | |
| + Claims Paid | 2,654.6 | 2,763.4 | 2,827.7 | 3,055.2 | 2,640.6 | — | — | |
| + Incurred Claims | 2,630.1 | 2,739.0 | 2,917.6 | 2,913.5 | 2,805.0 | 3,318.9 | 3,498.3 | |
| + Change in Outstanding Claims | -24.5 | -24.3 | 90.0 | -141.7 | 164.4 | — | — | |
| Insurance — Shareholders' Account | ||||||||
| + Income — Shareholders' Account | 14.2 | 367.2 | 96.0 | 192.7 | 170.2 | — | — | |
| + Shareholders' Investment Income | 97.0 | 118.0 | 115.0 | 123.4 | 104.6 | — | — | |
| + Transfer from Policyholders' Fund | -86.9 | 248.6 | -19.2 | 69.2 | 64.0 | — | — | |
| With Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Insurance — Result & Transfers | ||||||||
| Underwriting Profit / (Loss) | -275.2 | 71.7 | -204.1 | -125.0 | -154.3 | — | — | |
| Operating Profit / (Loss) | -86.9 | 248.6 | -19.2 | 69.2 | 64.0 | — | — | |
| + Other Income — Shareholders' Account | 4.1 | 0.5 | 0.2 | 0.1 | 1.7 | — | — | |
| Insurance — IRDAI Ratios (as filed, not percentages) | ||||||||
| Solvency Ratio (x, one scale) | 2.21 | 2.22 | 2.15 | 2.14 | 2.05 | 2.09 | 2.05 | |
| Solvency Ratio (as filed) | 2.21 | 2.22 | 0.02 | 2.14 | 2.05 | 2.09 | 2.05 | |
| Combined Ratio | 0.99 | 1.02 | 1.04 | 1.02 | 0.95 | — | — | |
| Incurred Claim Ratio | 0.69 | 0.70 | 0.72 | 0.69 | 0.65 | — | — | |
| Net Retention Ratio | 0.94 | 0.96 | 0.96 | 0.94 | 0.94 | — | — | |
| Expenses of Management Ratio | 0.30 | 0.33 | 0.33 | 0.34 | 0.30 | — | — | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||||
| Investor Complaints — During the Period | -1.00 | -1.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Investor Complaints — Disposed | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Related-party Transactions — During the Period | 7.5 | — | 5.2 | — | 6.8 | — | 14.6 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||||
| Net Income Adj (tax-effected) | — | — | — | — | — | 549.7 | 264.8 | |
| EPS Adj | — | — | — | — | — | 9.34 | 4.50 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||||
| Operating Expenses | 4,073.5 | 3,866.5 | 4,284.9 | 4,375.4 | 4,481.4 | — | — | |
| Other Operating Expenses | 225.5 | 225.0 | 235.4 | 261.1 | 255.1 | — | — | |
Filed with NSE on Tuesday, 27 October 2026 at 9:02 pm IST
Star Health and Allied Insurance (NSE: STARHEALTH) reported its Q2 FY27 results (July–September 2026) on Tuesday, 27 October 2026 at 9:02 pm IST. Consolidated net profit was ₹265 crore, up 382.3% from ₹54.9 crore in Q2 FY26 and down 51.8% from ₹550 crore in Q1 FY27.
Consolidated net profit was ₹265 crore, up 382.3% from ₹54.9 crore in Q2 FY26 and down 51.8% from ₹550 crore in Q1 FY27.
Consolidated net profit for the first half of FY27 (April–September 2026) was ₹815 crore, up 156.6% from ₹317 crore in the same months a year earlier.
Net profit by quarter: ₹128 crore in Q3 FY26, ₹111 crore in Q4 FY26, ₹550 crore in Q1 FY27 and ₹265 crore in Q2 FY27. That is ₹1,054 crore over the four quarters.
Against Q2 FY26, net profit was up 382.3% at ₹265 crore. Against Q1 FY27, net profit was down 51.8%.
Basic earnings per share were ₹4.50, against ₹0.92 in Q2 FY26.
Consolidated net profit was ₹557 crore in FY26 (April 2025–March 2026), down 13.8% from ₹646 crore in FY25.
On Tuesday, 27 October 2026 at 9:02 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 28 October 2025.
Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.
From Star Health and Allied Insurance's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 27 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.
Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.